Nurse Practitioner, Acute Care · Attleboro, MA
NPI
1205231081
Since 2014
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
20 Oneil Blvd
Attleboro, MA, 02703
Phone (508) 699-6165
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,532
70 services
Medicare patients, 2024
39
Average age 73
Drug cost, 2024
$12.7M
2,003 prescriptions
Company payments, 2025
$221
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary Whittenhall was code 99215 (office e&m - established), 48 times for 29 patients. In total Mary Whittenhall billed 70 services in 5 codes, and Medicare paid $6,532.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 48 | 29 | $104.71 | $5,026 |
| 99214 Office E&M - Established | Office | 15 | 14 | $68.27 | $1,024 |
By year: 2022 $11K for 100 services; 2023 $9,325 for 81 services; 2024 $6,532 for 70 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary Whittenhall prescribed most often to Medicare patients was Opsumit (Macitentan), with 230 prescriptions and refills. In total Mary Whittenhall wrote 2,003 Medicare prescriptions that cost $12.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 230 | 230 | 32 | $2.9M |
| Tyvaso Dpi Treprostinil | 174 | 174 | 25 | $4.0M |
| Tadalafil Generic | 152 | 160 | 22 | $181K |
| Ambrisentan Generic | 121 | 121 | 19 | $468K |
| Sildenafil Citrate Generic | 112 | 121 | 18 | $45K |
| Potassium Chloride Generic | 102 | 152 | 17 | $3,733 |
| Uptravi Selexipag | 88 | 88 | 12 | $2.1M |
| Furosemide Generic | 71 | 182 | 29 | $766 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 66 | 79 | 13 | $1,902 |
| Letairis Ambrisentan | 63 | 63 | 12 | $793K |
| Remodulin Treprostinil Sodium | 57 | 57 | Under 11 | $556K |
| Adcirca Tadalafil | 54 | 54 | Under 11 | $205K |
| Adempas Riociguat | 49 | 49 | Under 11 | $633K |
| Bumetanide Generic | 39 | 50 | Under 11 | $1,872 |
| Spironolactone Generic | 35 | 79 | 11 | $276 |
Brand drugs: 947 claims; generic drugs: 1,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary Whittenhall $221 ($221 in general payments such as food, travel and fees) from 2 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $200 |
| 3B Medical, Inc. | 1 | $20.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.